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Abstract 
INCREASED CIRCULATORY LIPOPOLYSACCHARIDE FROM A HIGH FAT 
DIET AGGRAVATES INFLAMMATION AND EXACERBATES RENAL 
FAILURE 
 
By: Samuel Maxfield Righi, MS. 
 
A Thesis submitted in partial fulfillment of the requirements for the degree 
of Master of Science at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2014 
 
Program Director: Dr. Leon Avery, Ph.D., Physiology 
 
 Kidney failure is frequently associated with the risk factors linked to 
metabolic syndrome. Lipopolysaccharide (LPS) is a potent inflammatory 
molecule, which has increased absorption from the gut into blood circulation 
following a high fat and high-energy diet. We hypothesized that LPS from a high 
fat diet can amplify inflammation, thereby exacerbating chronic kidney disease 
and associated disorders. We have found that adding a high fat diet to renal 
insufficient mice significantly progressed their kidney disease as well as 
associated disorders, compared to both a high fat diet and renal insufficiency 
alone. Additionally, we were able to demonstrate in vitro that the combination of 
LPS and palmitic acid, a marker of high fat diet, induced inflammatory pathways 
significantly more than either LPS or palmitic acid alone. These results provide 
insight into connection between a high fat diet and the progression of chronic 
kidney disease as well as associated disorders. 
 
 
 1  
Introduction 
 
1.1 Chronic Kidney Disease  
 Kidney failure is frequently associated with the risk factors of metabolic 
syndrome, including hypertension, glucose intolerance, and cardiovascular 
disorders such as atherosclerosis. The western style diet, characterized by highly 
processed foods with high contents of sugar and fat, is a major contributor to 
diseases associated with metabolic syndrome, such as type 2 diabetes and 
atherosclerosis, as well as contributing to increased incidences of chronic kidney 
disease (CKD) (1).  In a large cohort of over 320,000 patients it was found that 
body mass index (BMI) was a strong independent risk factor for end stage renal 
disease (ESRD), even after adjustment for other major risk factors that are 
associated with ESRD (2). However, the mechanisms by which metabolic 
syndrome due to high fat diet exacerbates CKD remain elusive and largely 
speculative. 
 In previous studies we have shown that high fat diet can produce 
atherosclerosis and glucose intolerance in LDL receptor knock out mice (LDLR-/-) 
(3, 4). Others have shown that partially nephrectomized LDLR-/- mice, a model of 
renal insufficiency, on a high fat diet experience vascular calcification, 
osteodystrophy and hyperphosphatemia (5). ApoE knockout mice, another model 
of atherosclerosis, have accelerated atherogenesis following uremia (6, 7). The 
major distinction between ApoE knockout and LDLR-/- mice is their response to 
diet.  On a routine chow diet, ApoE knockout mice have high cholesterol (400 to 
500 mg/dL) and atherosclerotic lesions, whereas the chow-fed LDLR-/- mice have 
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mildly increased plasma cholesterol levels (175 to 225 mg/dL) and usually do not 
develop significant atherosclerotic lesions (8). This suggests that environmental 
factors, such as diet, govern the development of atherosclerosis and glucose 
intolerance in LDLR-/- mice. We hypothesized that the nephrectomized LDLR-/- 
mouse would be a suitable model to elucidate the mechanism by which high fat 
diet can influence hypertension, renal dysfunction, glucose intolerance and 
atherosclerosis.  
 In addition, consumption of high fat diet can cause mild endotoxemia. 
Studies in both mice and men, show that direct manipulation of the gut 
microbiome improves features associated with metabolic syndrome and obesity, 
indicating that microbiota-based interventions are promising new targets for 
treating some diseases (9-11).   
 
1.2 LPS leakage  
 Lipopolysaccharide (LPS) is an endotoxin released by gram-negative 
bacteria that reside in the gut. While LPS usually remains in the gut, there are a 
variety of factors and conditions that can cause this LPS to seep out and into 
circulation. This occurs through changes in tight junction proteins, causing LPS to 
leak through the gut wall (Figure 1). It has been demonstrated that high fat, high-
energy diets alter gut microbiota and can cause leaky gut (9, 12).  Furthermore, 
recent studies have also provided considerable evidence that patients and 
animals with renal failure have altered gut microbiota that can result in increased 
intestinal permeability, leading to the leakage of inflammatory materials (13-16). 
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Once LPS is in the circulation it has the ability to bind to the TLR4 complex of a 
variety of cells that secrete inflammatory activating cytokines. Since both high fat 
diet and renal insufficiency are causes of leaky gut, we hypothesized that, when 
these two conditions are combined, a significant increase in LPS leakage from 
the gut into circulation will be observed. This increase in circulating LPS would 
further progress chronic kidney disease and associated disorders.   
 
1.3 Metabolic Syndrome 
 Metabolic syndrome is characterized by having at least one of the 
following risk factors: large waistline, high triglyceride levels, low HDL 
 
Figure 1. Diagram of LPS permeability through the gut wall. Schematic drawing depicting altered 
tight junction proteins, which allow for LPS permeability through the gut wall into circulation. 
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cholesterol, high blood pressure, and high resting blood glucose. Many of these 
risk factors accompany patients with chronic kidney disease. Additionally, 
patients with metabolic syndrome are up to 2.5 times more likely to develop 
chronic kidney disease than healthy individuals (17). Specifically, hyperglycemia 
and hypertension are the most influential factors in developing CKD, due to their 
role in predisposing patients to CKD and CKD progression (18-20). Although 
there is a strong association between metabolic syndrome and chronic kidney 
disease, the mechanism for the correlation is unknown.  We hypothesize that one 
of the connections between chronic kidney disease and the risk factors that make 
up metabolic syndrome is an increase in inflammation. More specifically, we 
believe LPS-induced inflammation could be an underlying cause for the 
progression of chronic kidney disease and associated metabolic syndrome 
disorders.  
 
1.4 Cytokines 
 A major contributor to the LPS-induced inflammatory signals is the binding 
of LPS to TLR4 on macrophages. This binding aids in the recruitment of immune 
cells to the location, as well as inducing the macrophage to secrete inflammatory 
cytokines that, when in excess, can cause kidney damage (21, 22). When used 
over short periods of time inflammatory cytokines can be very beneficial in 
fighting infection and foreign objects in the body; However, having these 
inflammatory cytokines linger in the body for too long can cause cellular damage 
and can further exacerbate many inflammatory conditions. Two of the cytokines 
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that are released via TLR4 activation that we examine in this study are TNF-α 
and IL-6.  We hypothesize that a high fat diet combined with kidney insufficiency 
increases circulating LPS, thereby increasing TLR4 signaling. Through migration 
signaling the total number of macrophages in the kidney will be increased, along 
with the levels of TNF-α and IL-6 secreted by macrophages. Ultimately this will 
lead to an increase in inflammation, which will further progress CKD and will 
aggravate associated disorders.  
 
1.5 Inflammation 
 Inflammation is a biological response by vascular tissue to harmful stimuli 
including viruses, bacteria, cell damage, and other irritants. Inflammation is 
caused when immune cells release chemicals in response to these harmful 
stimuli. The chemicals then initiate a number of complex cascades that cause an 
increase in blood flow to the specific area, which results in redness and swelling. 
Short-term inflammation, or acute inflammation, caused by cytokine release can 
be beneficial for the body to fight an infection. However, when these excess 
cytokines are present for long periods of time, known as chronic inflammation, 
they can cause significant harm to the body. Inflammation plays a large role in 
the body’s response to foreign material, but it also has a major role in a plethora 
of diseases and the progression of those diseases. Chronic kidney disease is 
associated with increased levels of inflammatory markers, and elevated 
inflammation can mediate loss of kidney function in patients with chronic kidney 
disease (23). Some of the factors of CKD that lead to increased inflammation 
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include malnutrition caused by decrease in appetite, anemia, and uremia. This 
increase in inflammation can further progress CKD, which will cause 
inflammation to rise even more. This ongoing cycle is a major danger associated 
with CKD and its associated disorders.  
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Materials and Methods 
 All antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, 
CA) unless otherwise stated. 
 
2.1 Animals 
 The Institutional Animal Care and Use Committees of Virginia 
Commonwealth University approved all animal procedures. Mice were divided 
into four groups with six animals in each group. The control group underwent 
sham surgery, and three other groups underwent 5/8th nephrectomy by the 
procedure described below. 
 
2.2 Surgery 
 Renal insufficiency was achieved by 5/8th nephrectomy where a quarter of 
the left kidney was ligated, followed by the removal of the right kidney 1 week 
later.  The surgical procedure was similar to the 5/6th nephrectomy done 
previously in our laboratory with slight modifications to achieve 5/8th (24). LDL 
receptor knock out (LDLR-/-) mice between 8-10 weeks were used in all 
experiments. All operations were carried out in sterile conditions under isoflurane 
anesthesia. In brief, a left flank incision was made, exposing the left kidney. The 
kidney was decapsulated and the lower quarter of the kidney was ligated, leaving 
the remaining 3/4th of the mass of the left kidney unharmed. The muscle and skin 
incisions were sutured with polypropylene suture. The animals were returned to 
the vivarium to recover. One week later, a right flank incision was made, the 
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renal vessels and ureter were ligated, and the entire right kidney was excised. 
Animals were returned to the vivarium to recover, and treatment was started after 
7 days. The animals were studied for 16 weeks and on the 17th week they were 
sacrificed.  
The animals were divided as follows: 
Control: Sham operated on normal chow diet 
Nx+Chow: Nephrectomized on normal chow diet 
HFD: Sham operated on high fat diet (TD 88137) 
Nx+HFD:  Nephrectomized on high fat diet (TD 88137) 
 
The normal diet is 5.8% fat by weight, accounting for 17% of the calories. The 
high fat diet is 21% fat by weight, accounting for 42% of the calories. The main 
source of fat for the high fat diet is anhydrous milk fat (butterfat). The fatty acid 
analysis of the anhydrous milk fat is 62.8% saturated fat, 27.3% 
monounsaturated fat, and 4.7% polyunsaturated fat.  
 
2.3 Pair fed high fat diet (PF-HFD)   
 In previous studies we have observed that nephrectomized animals 
experience a decrease in food consumption as compared to sham animals after 
8 – 10 days. As a result, we corrected for this difference by using a pair fed high 
fat diet (PF-HFD) group. At the start of treatment, the nephrectomized animals 
were given a weighed amount of high fat diet around 4 pm and permitted to eat 
ad lib.  The following evening the remaining food was weighed and the average 
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amount consumed was given to the sham operated animals and this group was 
designated PF-HFD. Since the food consumption of the sham control was more 
than the nephrectomized group we added normal chow to the PF-HFD group to 
prevent malnutrition. On average, the nephrectomized mice consumed 3/4th the 
amount of food of the control animals.   
 
2.4 Serum Urea Nitrogen, Serum Creatinine and Urinary Albumin 
 Serum urea nitrogen (urea) and creatinine were measured by a 
Quantichrom creatinine™ and Quantichrom urea assay™ kit. (Bioassay system; 
Hayward, CA).  Albumin was measured by mouse albumin ELISA assay kit 
(Bethyl Laboratories; Montgomery, TX). 
 
2.5 Lipopolysaccharide (LPS) measurement 
 Plasma LPS was analyzed by Lamilus Amebocyte Lysate (LAL) assay 
(Lonza, Walkersville, Maryland, USA) according to the manufacturer’s 
instructions, with the following modifications: samples were diluted 5-10-fold to 
avoid interference with background color and preheated to 70oC for 10 minutes 
prior to analyses. 
 
2.6 Longitudinal Measurement of Arterial Pressure by Tail 
Plethysmography 
 Arterial pressure (BP) was determined by tail plethysmography as 
previously described using the CODA 2 system (Kent Scientific, Torrington, CT) 
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(25). CODA 2 utilizes volume pressure recording sensor technology to measure 
tail blood pressure. This computerized, noninvasive tail-cuff acquisition system 
can simultaneously measure systolic, diastolic, and mean arterial pressure 
without operator intervention. Before surgery, mice were conditioned over a 
period of 3 days and kept in a restraining holder for a 5- to 10-min period. On the 
fourth day, BP was recorded (week 0). During this period, 25 sequential readings 
were obtained. Readings within a range of 10 mmHg were averaged. Two weeks 
after the second surgery, the animals were retrained and BP was recorded every 
alternate week. In this study, we report the mean arterial pressure (MAP) of each 
group. 
 
2.7 Histology 
 Animals from each group were examined for histological changes in the 
kidney. A portion of the kidney was cut and fixed in 10% buffered formalin for 
light microscopy. Sections were cut at 2-µm thickness and stained with periodic 
acid-Schiff. A basic scoring system was used, as described previously (25). A 
minimum of 100 glomeruli was scored per animal by an observer blinded to the 
origin of the tissue.  
 
2.8 Intraperitoneal Glucose Tolerance Tests (IPGTT): 
 IPGTTs were carried out as described previously (17).  Briefly LDLR−/− 
mice of different cohorts were fasted overnight and given a single bolus of 
glucose (2 mg/g body weight) intraperitoneally. Blood glucose levels were 
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determined using a commercially available glucometer and tail vein blood at 0 
minutes (before IP injection), 15, 30, 60, and 120 minutes after IP administration. 
 
2.9 Quantitative atherosclerosis analyses.  
 Quantitative atherosclerotic enface analysis was carried out as described 
before (26). Briefly the aorta was dissected from the heart to the iliac bifurcation, 
cleaned of any surrounding tissue, opened longitudinally, pinned on black wax, 
and fixed for 24 h in 10% buffered formalin. The fixed aortas were imaged on a 
black background using a Canon digital camera fitted with a 60-mm, f/2.8-macro 
lens. Total area and area occupied by the lesions in the aortic arch and total 
aorta were determined using Axiovision Image Analysis software (Carl Zeiss). 
The person quantifying the area occupied by lesions was blinded to the identity 
of the images. Extreme care was taken to ensure that any residual adventitial fat 
that appeared translucent on the images was not included in the area occupied 
by the lesions that were dense and opaque. 
 
2.10 Homogenization 
 Each kidney was removed and immediately frozen in liquid nitrogen and 
kept at −70°C until use. The frozen kidney was ground to a powder and then 
mixed in ice-cold RIPA buffer (Thermo Fisher Scientific, Rockford, IL) and 
protease and phosphatase inhibitors. The kidney was homogenized in an ice-
chilled Dounce homogenizer at 4°C, and centrifuged at 4oC at 2500 rpm for 5 
minutes.  The supernatant was aliquoted and stored at −70°C until use.  
 12  
 
2.11 Immunoblotting 
 Kidney homogenates (75–100 µg total protein) were separated on a 4–
20% SDS-PAGE gel, and proteins were transferred to a polyvinylidene difluoride 
membrane as described before (24). Blots were washed briefly in phosphate-
buffered saline containing 1% Tween 20 (PBS-T) and blocked in 5% nonfat dry 
milk, followed by incubation with appropriate antibodies in 5% nonfat dry milk 
overnight at 4°C. Following three to five washes in PBS-Triton X-100, blots were 
subsequently incubated with secondary antibody appropriately diluted in 5% 
nonfat dry milk for 1 hr at room temperature. Blots were washed three to five 
times in PBS and were developed using Lightning Chemiluminescence Reagent 
Plus and exposed to X-rays. 
 
2.12 Cell Culture 
 Transduction with recombinant adenoviruses: NFkB-Luciferase 
adenovirus (NFkB-adluc) was obtained from Vector Biolabs (Philadelphia, PA).  
Expression of the luciferase gene is controlled by a synthetic promoter that 
contains direct repeats of the transcription recognition sequences for the binding 
sites for NFkB. Mouse macrophages (J774) cultured in DMEM were infected 
overnight at a multiplicity of infection (MOI) of 5 at 37°C.  Cells were exposed 
to palmitic acid (0, 150 µM, 300 µM and 600 µM), 50 pg/mL LPS (low dose LPS), 
or 50 pg/mL LPS (high dose LPS), followed by incubation for 4 hours. Cells 
undergoing a second round of palmitic acid treatment were washed twice with 
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sterile PBS, followed by palmitic acid treatment (0, 150 µM, 300 µM and 600 µM), 
and incubation for an additional 4 hours. After respective incubations the cells 
were lysed and assayed for luciferase activity using the Promega kit. 
 
2.13 Mouse macrophage (J774) for Western Blots 
 Non-transduced J774 cells cultured in DMEM were treated with palmitic 
acid (0, 150 µM, 300 µM and 600 µM) and/or LPS as described above. After 
appropriate incubation time intervals the cells were lysed in RIPA buffer and were 
centrifuged at 2500 rpm for 5 minutes followed by processing for western blots as 
described above in the immunoblotting section.  
 
2.14 Isolation of Peritoneal Macrophages:  
 Thioglycollate-elicited peritoneal macrophages were harvested, and non-
adherent cells were removed after 2 hr, and medium was replaced with fresh 
growth medium (4). For determination of gene expression, total RNA was 
isolated from adherent macrophages 2 hr after plating using the RNeasy kit from 
Qiagen. 
 
2.15 Quantitative Real-Time RT-PCR Analysis 
 Total RNA was extracted from kidneys with the RNeasy Mini Kit as 
described previously (24). Briefly, 2 µg of total RNA were reverse transcribed 
with the Thermoscript RT-PCR System (Invitrogen), and first-strand cDNA was 
used to perform real-time PCR using the Stratagene Mx3000p real-time PCR 
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system with TaqMan Universal PCR Master Mix and optimized probe and primer 
sets from Applied Biosystems (Foster City, CA). The following probes were used: 
CD36 Mm00432403_m1), SR-A (Mm00446214_m1), IL-6 (Mm00446190_m1) 
and TNF-α (Mm00443258_m1). The amount of mRNA was calculated by the 
ΔCT method and normalized to β-actin. 
 
 
2.16 Statistical Analysis 
Statistical comparisons among groups were performed using ANOVA followed by 
Tukey's multiple comparison test. Groups were considered to be significantly 
different at p ≤ 0.05 – p ≤ 0.001. 
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Results 
3.1 Diet and Weight 
 In previous studies it has been observed that weight loss is associated 
with renal insufficiency. In order to examine the role of weight in our model, we 
obtained the average weight of the mice in each treatment group. Mice that were 
fed a high fat diet experienced a 45% increase in body weight compared to the 
controls (p < 0.01) (Figure 2). The average body weight of control animals was 
26.7 ± 2 grams, which was 21% higher (p < 0.01) than the nephrectomized 
animal on normal diet (Nx+Chow), but was not significantly different from the 
nephrectomized animals on high fat diet (Nx+HFD).  Two weeks after the surgery 
we observed that the total intake of food was noticeably less for the 
nephrectomized animals compared to the control animals. In order to decrease 
the influence of appetite suppression induced by CKD, we introduced a pair fed 
control group as described in the methods. The average weight of PF-HFD was 
 
Figure 2. Average body weight of mice after the 16-week experiment. The significant 
changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; 
†p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; ‡ 
p < 0.05 from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
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32.9 ± 2.9 gms, which was 17% lower than HFD group but significantly higher 
than the control, Nx+Chow and Nx-HFD (p < 0.05). The average body weight of 
Nx+HFD (26.5+5.6 gms) was significantly higher than Nx+Chow (p < 0.05).  
  
3.2 Blood Pressure 
 One of the characteristic risk factors for metabolic syndrome is high blood 
pressure. To assess the effects of high fat diet and renal insufficiency on blood 
pressure, we measured the mean arterial pressures (MAP) of the groups over 
the course of the experiment. For the first six weeks there was not a significant 
difference between the MAPs of the groups. After six weeks both the Nx+Chow 
and Nx+HFD MAP started to significantly increase, and remained elevated 
compared to the other groups. Figure 3 displays the longitudinal changes in MAP 
for the groups over the 16-week period. The MAP of the control cohort did not 
show a significant change over the course of the experiment. It ranged from 95 ± 
6.3 mm Hg at the start of the experiments to 102 ± 5.4 mm Hg, at 16 weeks.  The 
high fat diet given ad lib (HFD; data not shown) and pair fed high fat diet (PF-
HFD) were not significantly different from each other or the control at the end of 
the 16-weeks.  The mean MAP of Nx+Chow at 6, 12 and 16 weeks were 107 ± 
2.7 mm Hg, 134 ± 19.6 mm Hg, and144 ± 18.6 mm Hg respectively. The mean 
MAP of Nx+HFD at 6, 12 and 16 weeks were 111.5 ± 2.380, 154.0 ± 5.89 mm 
Hg, and 164.5 ± 6.19 mm Hg.  Between 6 to 16 weeks the MAP of Nx+Chow and 
Nx+HFD were significantly higher than control and PF-HFD (p < 0.01).  After 8 
weeks the MAP of Nx+HFD was consistently higher than the Nx+Chow, however 
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the difference was not statistically significant. 
 
 
3.3 Urinary Albumin Creatinine Ratio (ACR) 
 The ratio of albumin to creatinine is an indicator of many conditions known 
to be associated with metabolic syndrome, and additionally can be affected by 
kidney dysfunction. As such, we measured the urinary albumin creatinine ratio 
(ACR) through the duration of our experiment. Over the course of the first four-
weeks there was not a significant difference in ACR between the groups. From 4-
weeks on, all of the treatment groups had an ACR significantly higher than the 
control group. At 8 weeks the HFD, NX-Chow, and NX-HFD groups had ACR 
levels significantly more than the PF-HFD group. From 12-weeks to 16-weeks 
 
Figure 3. Mean arterial pressures (MAP) plotted over the 16-week experiment. The 
significant changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 
from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 
0.01 from HFD; ‡ p < 0.05 from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
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the ACR levels were from lowest to highest as follows: control, PF-HFD, HFD, 
NX-Chow, and NX-HFD.  All of the ACR values of the groups were significantly 
different from one another at the end of the 16 weeks as displayed in Figure 4. At 
the end of 16 weeks the ACR of control, HFD, PF-HFD, Nx+Chow and Nx+HFD 
were 6.2 ± 1.52, 91.5 ± 9.91, 36.7 ± 7.09, 233.7 ± 63.70, and 391.2 ± 59.64 
respectively.  The significant differences among the groups at the end of 16 
weeks are as follows NX+HFD > Nx+Chow (p < 0.05); Nx+Chow > HFD (p < 
0.05) and HFD > PF-HFD (p < 0.01).  All the groups were significantly higher 
than control. 
 
3.4 Serum Urea and Serum Creatinine  
 In order to assess the level of kidney function in our mice, we measured 
serum urea and serum creatinine levels at the end of the treatment, as 
 
Figure 4. Urinary albumin creatinine ratio (ACR) plotted over the 16-week experiment. The 
significant changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 
from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 
0.01 from HFD; ‡ p < 0.05 from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
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represented in Figure 5 and Figure 6 respectively. The serum urea and creatinine 
of the animals on PF-HFD (data not shown) were not significantly different from 
HFD and control.  The serum urea of the Nx+Chow group (36.4 ± 5.6 mg/dL) was 
more than 45% higher than control and PF-HFD (p < 0.05). The serum urea of 
Nx+HFD (55.5 ± 16.1mg/dL) was about 60% higher than the control and PF-HFD 
(p < 0.01) and significantly higher than Nx+Chow (p < 0.05).  As shown in Figure 
6, serum creatinine of the control (0.45 ± 0.07 mg/dL) was not significantly 
different from PF-HFD (0.5 ± 0.09 mg/dL).  Serum creatinine levels of Nx+Chow 
(0.7 ± 0.04 mg/dL) were significantly higher than both control and PF-HFD 
groups (p < 0.05). The creatinine level of Nx+HFD group (0.9 ± 0.04 mg/dL) was 
also significantly higher than the control and the PF-HFD cohorts (p < 0.01). In 
addition, the serum creatinine of Nx+HFD was significantly higher than Nx+Chow 
(p < 0.05).  These data suggest that a high fat diet may not induce renal failure 
by itself, but has the capability of intensifying renal insufficiency.  
 
 
Figure 5. Serum urea levels after 16-weeks. The significant changes are represented by the 
following signs, *p < 0.05 from control; **p < 0.01 from control; †p < 0.05 from PF-HFD; †† p < 
0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; ‡ p < 0.05 from Nx+Chow;;  and 
‡ ‡ p < 0.01 from Nx+Chow. 
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3.5 Histology  
 Previous studies in the lab with 5/6th nephrectomized rats displayed global 
and segmental sclerosis with tubular dilation and atrophy (24, 25). In contrast, 
our 5/8th nephrectomized mice displayed only large vacuoles and protein droplets 
but no significant sclerosis or tubular damage (data not shown) were present. 
This suggests that this is a model of renal insufficiency, rather than renal failure. 
 
3.6 Lipopolysaccharide (LPS) and Macrophages 
 LPS is an endotoxin released by gram-negative bacteria, which elicits an 
immune response in animals, including inflammation. Both humans and mice 
have increased absorption of LPS from the gut into the circulatory system 
following a high fat/high energy diet (27). To this end, we measured LPS serum 
LPS levels for all groups at the end of the 16-week experiment, as displayed in 
 
Figure 6. Serum creatinine levels after 16-weeks. The significant changes are represented by 
the following signs, *p < 0.05 from control; **p < 0.01 from control; †p < 0.05 from PF-HFD; †† p 
< 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; ‡ p < 0.05 from Nx+Chow;;  
and ‡ ‡ p < 0.01 from Nx+Chow. 
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Figure 7. The serum LPS levels for the control group (0.4 ± 0.07 EU/mL) were 
significantly less than the other treatment groups. The PF-HFD group serum LPS 
levels (1.57 ± 0.29 EU/mL) were significantly more than the controls, however 
they were significantly less than the other three groups. The HFD (3.00 ± 0.40 
EU/mL) and NX-Chow (2.34 ± 0.35 EU/mL) treatment groups had serum LPS 
levels significantly more than the control and PF-HFD groups, but they were not 
significantly different from one another. The NX-HFD treatment group had the 
highest serum LPS levels (4.13 ± 0.74 EU/mL), and they were significantly above 
the other groups. The relationship of the serum endotoxin levels between the 
groups are as follows: Nx+HFD > HFD > Nx+Chow = PF-HFD. These data 
suggest that renal insufficiency can affect serum LPS levels. Furthermore, the 
endotoxin levels appear to increase due to the consumption of high fat diet. 
 
Figure 7. Serum LPS levels in mice at the end of 16 weeks. At the end of 16 weeks the 
animals were sacrificed and serum lipopolysaccharide (LPS) was measured by Lonza Assay kit  
The significant changes are represented by the following signs, *p < 0.05 from control; **p < 
0.01 from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p 
< 0.01 from HFD; ‡ p < 0.05 from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
 
 22  
 Bacterial endotoxin LPS, can activate migration of macrophages to 
various organs by binding to the macrophage TLR4 receptors (28). The influx of 
macrophages in the kidney was evaluated by quantitation of macrophage 
markers CD-68 and SR-1 in the kidney by RT-PCR.  As seen in Figures 8 and 9, 
all the groups (HFD, PF-HFD, Nx+Chow and Nx+HFD) had higher macrophage 
markers than the control. The maximum influx of macrophages in the kidney was 
in the Nx+HFD group followed by Nx+Chow.  Both the macrophage markers in 
the Nx+HFD group were 1.5 times higher than the Nx+Chow (p < 0.05).  The 
macrophage influx in the Nx+HFD and Nx+Chow was not only higher than PF-
HFD (p < 0.01) but was also significantly higher than HFD (p < 0.05) suggesting 
renal injury promotes higher macrophage infiltration in LDLR-/- mice. This influx of 
macrophages following renal injury can be aggravated by high fat diet.     
 
 
 
Figure 8. Macrophage marker CD 68 was measured using QPCR. The level of this maker 
represents the magnitude of macrophage influx in the kidney The significant changes are 
represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; †p < 0.05 
from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; ‡ p < 0.05 
from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
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3.7 Cytokines 
 There is a strong correlation between inflammation and renal failure (29). 
Specific cytokines released by macrophages during an immune response can 
lead to increased inflammation. To examine the role of cytokines during renal 
failure we looked at the levels of inflammatory cytokines IL-6 and TNFα in the 
kidney. The increase in kidney TNFα of Nx+HFD, Nx+Chow HFD and PF-HFD 
from the control were 10 fold, 5.8 fold, 3.7 fold, and 2.6 fold respectively. Figure 
10 shows that all of the treatments groups had significantly higher levels of TNFα 
compared to the control. The highest levels of TNFα came from the Nx+HFD 
group, which was significantly higher than rest of the groups. The TNFα levels in 
the kidney of PF-HFD were significantly lower than HFD (p < 0.05) and Nx+Chow 
(p < 0.01).  The TNFα in the Nx+Chow kidney was significantly higher than HFD 
(p < 0.05).   
 
Figure 9. Macrophage marker SR1 was measured using QPCR. The level of this maker 
represents the magnitude of macrophage influx in the kidney The significant changes are 
represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; †p < 0.05 
from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; ‡ p < 0.05 
from Nx+Chow;;  and ‡ ‡ p < 0.01 from Nx+Chow. 
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 The increase in kidney IL-6 of Nx+HFD, Nx+Chow HFD and PF-HFD from 
the control was 7.3 fold, 4.2 fold, 2.7 fold, and 2.4 fold respectively. As shown in 
Figure 11, they were all significantly higher than the control. Similar to TNFα, the 
IL6 levels were the highest in the Nx+HFD group, and they were significantly 
higher than rest of the groups as displayed by Figure 11.  Also, the IL-6 levels in 
Nx+Chow were significantly higher than HFD (p < 0.05) and PF-HFD (p < 0.05).     
 
 
 
 
Figure 10. Kidney TNFα levels measured by QPCR at the end of 16 weeks. The significant 
changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; 
†p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; 
and  ‡ p < 0.05 from Nx+Chow. 
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 We also looked at the cytokine levels of peritoneal macrophages activated 
through treatment with thioglycolate.  As seen in Figures 12 and 13, the changes 
in both the cytokines in the macrophages were qualitatively similar to the kidney 
cytokines. It is possible that the increased influx of macrophages contributed to 
the increase in cytokine levels; however, during this study we did not determine 
the precise influence that macrophages alone had on the increased kidney 
cytokine levels.  
 
 
 
 
 
Figure 11. Kidney IL-6 levels measured by QPCR at the end of 16 weeks. The significant 
changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; 
†p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD; 
and  ‡ p < 0.05 from Nx+Chow. 
. 
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Figure 12. Activated macrophage TNFα levels measured by QPCR. Thioglycholate elicited 
macrophages were plated as described in the methods, and TNFα levels were measured by 
QPCR.The significant changes are represented by the following signs, *p < 0.05 from control; 
**p < 0.01 from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; 
## p < 0.01 from HFD; and  ‡ p < 0.05 from Nx+Chow. 
 
 
 
Figure 13. Activated macrophage IL-6 levels measured by QPCR. Thioglycholate elicited 
macrophages were plated as described in the methods, and IL6 levels were measured by 
QPCR. The significant changes are represented by the following signs, *p < 0.05 from control; 
**p < 0.01 from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; 
## p < 0.01 from HFD; and  ‡ p < 0.05 from Nx+Chow. 
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3.8 Intraperitoneal Glucose Tolerance Tests (IPGTT) 
 High fat diet and renal failure are usually accompanied by hyperglycemia. 
To this end, we carried out intraperitoneal glucose tolerance tests (IPGTTs). 
Figure 14 depicts the blood glucose levels of the groups at various time intervals.  
In our IPGTT study the blood sugar of the control at 0 hour (before IP glucose 
administration) was significantly lower than the rest of the cohorts (p < 0.05-
0.01). The blood glucose of the Nx+HFD cohort was significantly higher than the 
rest of the groups at all-time points. 15 minutes after glucose administration, the 
NX-HFD group was the only treatment group that was significantly higher than 
the control. After 30 minutes the NX+Chow group had glucose levels significantly 
higher than the control. The HFD and NX-HFD had significantly higher glucose 
levels than the NX+Chow, PF-HFD, and control. After 60 minutes the NX+Chow 
and PF-HFD groups had glucose levels remained significantly higher than the 
control, and both the HDF and NX-HFD groups were significantly more than the 
NX+Chow and PF-HFD. After 90 minutes the NX+Chow, PF-HFD, and HFD 
groups had significantly increased glucose levels compared to the control, but 
were not significantly different from one another. The NX-HFD group had glucose 
levels significantly more than all the other groups.  
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Figure 14. Blood glucose concentration after intraperitoneal injection of 2mg/g glucose. 
After overnight fasting the tail was clipped and blood glucose was measured by a commercial 
glucometer for the 0 hour sample.  Following the 0 hour sample 2 mg/g glucose was 
administered and blood concentration versus time is shown. The significant changes are 
represented by the following signs, *p < 0.05 from control; **p < 0.01 from control; †p < 0.05 
from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 0.01 from HFD;  and ‡ p < 
0.05 from Nx+Chow;. 
 
Figure 15. Area under the curve of blood glucose levels from 0-120 minutes. The 
significant changes are represented by the following signs, *p < 0.05 from control; **p < 0.01 
from control; †p < 0.05 from PF-HFD; †† p < 0.1 from PF-HFD; # p < 0.05 from HFD; ## p < 
0.01 from HFD; and ‡ p < 0.05 from Nx+Chow;. 
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 Figure 15 shows the area under the curve of glucose concentration versus 
time (0-120 minutes) calculated for each cohort. The Nx+HFD group was 
significantly higher than its pair fed control (PF-HFD; p < 0.01) and was even 
higher than HFD group (p < 0.05) and Nx+Chow (p < 0.05).  Although the AUC of 
Nx+Chow was higher than control it was not significantly different from PF-HFD.  
 
3.9 Atherosclerotic Lesions 
 Increased rates of cardiac death are a common feature in patients with 
renal failure.  End stage renal failure patients have been shown to have enlarged 
coronary plaques compared to non-uremic patients, and this could contribute to 
the increased cardiac complications in renal failure patients (30). To test the 
impact of our treatments on cardiovascular health we examined the percent area 
of the aorta covered with atherosclerotic lesions by using en face analyses. 
Figure 16 shows representative images of aortae obtained from HFD, PF-HFD 
and Nx+HFD groups.  The control animals and Nx+Chow group did not show any 
lesions. Therefore these groups were not included in our analyses. In the HFD 
group 20.2 ± 3.7 % area of the aortae were covered by lesions as seen in Figure 
17. Although the Nx+HFD (25.5 ± 6.9 % lesion area) had more lesions than HFD, 
it was not significantly different. In our preliminary study we had observed this 
effect and realized that the food consumption of Nx+HFD was significantly lower 
than the non-nephrectomized HFD group.  Since diet influences the extent of 
atherosclerosis, we introduced a pair fed high fat diet group (PF-HFD) as 
described in the methods. This PF-HFD group allowed us to evaluate the effect 
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that renal failure alone had on atherosclerosis by feeding two separate groups 
the same amount of high fat diet by weight. This allowed us to deduce that any 
changes that were seen were due to renal failure and not from the high fat diet. 
There was no significant difference in the lesion area between HFD and PF-HFD.  
However, the aortic lesions of the Nx+HFD were 1.8 fold higher than PF-HFD (p 
< 0.01) suggesting that the diet influenced the aortic lesions in the animals with 
renal insufficiency. 
 
 
 
Figure 16. En face pictures of the atherosclerotic lesion in the arteries and analysis of the 
lesion area. 
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3.10 In vitro study to determine interaction of Palmitic acid (PA) and LPS 
 The level of activation of NFkB was assessed in order to measure 
inflammatory response.  Mouse macrophages (J774) were transduced with 
adenoviral NFkB with a luciferase reporter and treated with different 
concentrations of PA and LPS. Figure 18 and Figure 19 show the changes in 
NFkB luciferase activity with various concentrations of PA and LPS, and LPS 
alone. Figure 20 shows the changes in NFkB luciferase activity following PA and 
LPS treatment. The lower dose of LPS (50 pg/mL) did not significantly affect 
NFkB luciferase reporter activity. The higher dose of LPS (50 ng/mL) caused a 
drastic increase in NFkB luciferase reporter activity, 33 fold higher (p < 0.001) 
than the control.  In humans, after consumption of 1 gram of fat per kg of body 
 
Figure 17. Percent of area of aorta occupied by atherosclerotic lesions. The area occupied 
was highest in the Nx+HFD group, and it was significantly higher than the PF-HFD cohort but 
not HFD group.  There were no significant atherosclerotic lesions in control and Nx+Chow 
therefore they were not included. 
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weight, plasma levels of PA (between 2-8 hours) ranged from 100 µM to 600 µM 
(31). As a result, we measured the ability of various physiologically relevant 
concentrations of PA, combined with a high fat diet, to activate NFkB.  J774 cells 
were treated with 150 µM PA, 300 µM PA and 600 µM PA in the presence or 
absence of low dose LPS (50 pg/mL). As seen in Figure 19, compared to control 
the activation of NFkB by low dose LPS alone was not significantly different.  
Activation of NFkB by 150 µM PA alone was not significantly different from the 
control, however 300 µM and 600 µM had 5 fold (p < 0.05) and 11 fold (p < 0.01) 
higher NFkB luciferase activity respectively. Furthermore, when the cells were 
exposed to low dose LPS and subsequently treated with 150 µM PA, the 
increase in NFkB luciferase was 5 fold higher than cells treated with the same 
concentration of PA without LPS exposure (p < 0.01). Similarly the cells treated 
with LPS and given 300 µM PA had 3 fold higher NFkB luciferase than cells 
treated with 300 µM PA alone (p < 0.05), clearly showing that even small doses 
of LPS exaggerate fatty acid mediated inflammation.     
 
 
 
 33  
 
 
Figure 18. NFkB adeno viral activation by PA. The significant changes are 
represented by the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p 
< 0.01 vs 300 µM PA; and †† p < 0.01 vs LPS 50 ng.   
 
 
Figure 19. NFkB adeno viral activation by LPS. The significant changes are represented by 
the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p < 0.01 vs 300 µM PA; 
and †† p < 0.01 vs LPS 50 ng.   
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 We further confirmed this by looking at the phosphorylation of NFkB by 
immunoblot analysis. Increased phosphorylation i.e. increased ratio of 
pNFkB/NFkB, reflects augmented inflammation. Figure 21 and Figure 22 show 
the changes in pNFkB/NFkB ratio with various concentrations of PA and LPS 
alone. Figure 23, shows the changes in the pNFkB/NFkB ratio when the PA 
treated cells were pretreated with a low dose of LPS. Figure 22 shows PA was 
able to independently increase phosphorylation of NFkB. The higher 
concentrations of PA (300 µM and 600 µM) were significantly higher than the 
control (p < 0.05 and p < 0.01 respectively).  Compared to the cells treated only 
with PA, cells exposed to low dose LPS followed by 150 and 300 µM PA had 2-
fold higher NFkB phosphorylation (p < 0.01). The results of the immunoblot 
experiments were qualitatively similar to the adenoviral study.  
 
Figure 20. NFkB adeno viral activation by PA and/or LPS. The significant changes are represented by 
the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p < 0.01 vs 300 µM PA; and †† p < 
0.01 vs LPS 50 ng. 
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Figure 21. NFkB phosphorylation induced by PA. The significant changes are represented 
by the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p < 0.01 vs 300 µM 
PA; and †† p < 0.01 vs LPS 50 ng.   
 
 
Figure 22. NFkB phosphorylation induced by LPS. The significant changes are represented 
by the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p < 0.01 vs 300 µM 
PA; and †† p < 0.01 vs LPS 50 ng.   
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Figure 23. NFkB phosphorylation induced by PA and/or LPS. The significant changes are 
represented by the following signs: ** P < 0.01 Vs control;  ‡ P < 0.01 vs 150 µM PA; #p < 0.01 
vs 300 µM PA; and †† p < 0.01 vs LPS 50 ng.   
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Discussion 
4.1 Impact on Overall Kidney Function  
 In order to determine the magnitude of impact that a high fat diet 
combined with renal insufficiency has on overall kidney function we measured 
serum urea and serum creatinine levels.  The serum urea and creatinine levels 
obtained after the 16-week experiment are displayed in Figures 5 and 6. The 
high fat diet alone was unable to significantly alter kidney function as indicated by 
the resulting serum urea and serum creatinine levels. As expected, when 
nephrectomy was performed the overall kidney function was significantly 
decreased. The serum urea and creatinine levels in the NX-Chow group were 
significantly higher than the levels seen in both the control and HFD groups. The 
most substantial impairment of kidney function occurred when a high fat diet was 
combined with nephrectomy. The NX-HFD group’s serum creatinine and urea 
levels were significantly higher than the three other treatment groups. These 
results indicate that a high fat diet alone cannot diminish kidney function, but 
when combined with an already compromised kidney it can intensify the kidney 
dysfunction.  This also suggests that healthy kidneys performing optimally are 
able to handle the stresses accompanied by a high fat diet, but when there is a 
decrease in kidney function the stresses from the high fat diet are overwhelming 
and aggravate the decrease in kidney function.  
 
4.2 Metabolic Syndrome  
 Kidney failure is often coupled with hypertension, glucose intolerance, 
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cardiovascular disorders, as well as other conditions that make up metabolic 
syndrome. We wanted to elucidate how a high fat diet during renal insufficiency 
could affect some of the conditions that make up metabolic syndrome. To do this 
we collected data on body weight, blood pressure, albumin creatinine ratio, 
glucose tolerance, and atherosclerotic lesions from the mice.  
 Excess weight, especially in the form of abdominal visceral fat is one of 
the main risk factors for metabolic syndrome as well as many other health 
conditions. Decrease in appetite due to renal insufficiency can lead to weight 
loss, and this weight loss has been seen previously in our lab in rats suffering 
from CKD (24). In this study we observed that the average body weight of control 
animals was significantly higher than the nephrectomized animal on a normal 
diet, but was not significantly different from the nephrectomized animals on high 
fat diet. Excess weight can cause increases in inflammation, blood pressure, and 
atherosclerotic lesions, affect glucose tolerance, and aggravate many other 
conditions. The uremic animals on normal diet had significant weight loss, which 
was offset by high fat diet; however, the weight gain of Nx+HFD animals was still 
significantly lower than the pair fed group. This suggests that diet contributed 
more than weight gain in inducing the metabolic changes. Renal insufficiency can 
cause a variety of metabolic changes, but these changes are due to outcomes 
other than weight gain.  
 Similar to human patients with CKD, our renal insufficient mouse model 
displayed significantly increased blood pressure after the 16-week experiment. 
Having an increase in blood pressure can cause too much stress on the blood 
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vessels in the kidneys, which can cause damage and decrease function. 
Nephrectomy alone was able to increase the MAP significantly more than both 
the control and the PF-HFD groups. The NX-HFD group had the highest MAP out 
of all the cohorts at the end of the experiments, and they were significantly higher 
than the rest of the treatment groups. These results demonstrate that a high fat 
diet alone did not have a significant impact on MAP, but nephrectomy alone did. 
When a high fat diet was added to renal insufficient mice it was able to increase 
blood pressure significantly compared to the NX-Chow group. This suggests that 
healthy kidneys are not overwhelmed by a high fat diet in terms of its affect on 
MAP, but when that same high fat diet is given to renal insufficient mice there is a 
significant increase in blood pressure. Damaged kidneys are not able to deal with 
the added stresses that come from a high fat diet, and this can result in an 
increase in blood pressure. Our mouse model showed that renal insufficiency 
can cause an increase in blood pressure, and this increase in blood pressure can 
further exacerbate the renal insufficiency. This cycle can cause drastic and 
dangerous decreases in overall kidney health and kidney function.  
 The albumin creatinine ratio (ACR) is an indicator of many conditions 
associated with metabolic syndrome including cardiovascular disease, 
hypertension, glucose intolerance, and many others. Kidney dysfunction can 
cause albumin to leak into the urine and this will result in an increased ACR ratio. 
Although kidney failure is one way to increase ACR, many of the other indicators 
of metabolic syndrome, diabetes for example, have the ability to increase ACR. 
Our results indicate that a high fat diet alone is able to significantly increase the 
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ACR compared to the control. These results were expected due to the fact that a 
high fat diet alone can increase blood pressure, glucose intolerance, and 
cardiovascular disease. The NX-chow group had a significant increase in ACR 
compared to the control, HFD, and PF-HFD group. This demonstrates that 
kidney insufficiency alone has a bigger impact on the ACR than diet alone. When 
a high fat diet was added to renal insufficiency this created the highest ACR 
levels and they were significantly higher than all the other groups. This once 
again indicates that damaged kidneys are not able to cope with the stresses of a 
high fat diet, and this can causes dramatic metabolic and physiological changes. 
Figures 5 and 6 display that a high fat diet alone was unable to decrease kidney 
function (no significant change in either serum urea or creatinine compared to the 
control), however it was able to significantly increase the ACR. This denotes that 
the increase in ACR caused by the high fat diet is the result of changes other 
than kidney dysfunction.  
 High fat diet is known to cause glucose intolerance and atherosclerosis in 
LDLR-/- mice. We wanted to examine how this high fat diet combined with renal 
insufficiency would affect glucose intolerance and atherosclerosis. Figure 14 
displays the blood glucose levels of the groups at various time intervals, and 
Figure 15 displays the area under the curve (AUC) for each treatment group. 
After 120 minutes the HFD, PF-HFD, and NX-chow groups had glucose levels 
that were significantly increased compared to the control, but they were not 
significantly different from one another. This demonstrates that a high fat diet 
alone, and renal insufficiency alone, have the capacity to significantly decrease 
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glucose tolerance. When the high fat diet was combined with renal insufficiency it 
resulted in the highest glucose levels of all the treatment groups. Some of the 
roles the kidney has in glucose regulation involve releasing glucose into 
circulation by gluconeogenesis, uptake of glucose from the circulation for energy, 
and reabsorption of glucose in the proximal tubule. The NX-HFD group has 
significantly higher glucose levels compared to all the other groups starting as 
early as 15 minutes after glucose administration, until the end of the 2-hour 
experiment. Our results form the serum creatinine and serum urea levels 
indicated that a high fat diet combined with renal insufficiency resulted in a 
significant decrease in overall kidney function. This decrease in overall kidney 
function could explain the kidneys decrease in ability to regulate blood glucose 
levels. From these data it can be speculated that high fat diet is not only a strong 
inducer of glucose intolerance but can play a major role in aggravating 
hyperglycemia in renal failure. 
 Using en face analysis we were able to determine the percentage of the 
aorta that was obstructed by atherosclerotic lesions. There was no statistical 
difference between the HFD and the PF-HFD groups. The NX-HFD group was 
also not significantly different from the HFD group, but the percentage occluded 
by lesions was significantly higher in the NX-HFD group than the PF-HFD group. 
Both of these groups were fed the same amount of the high fat diet, the only 
difference between them was the NX-HFD group was renal insufficient. These 
data emphasizes the importance of the kidneys for lipid metabolism and 
regulation of circulating lipids. The kidneys have a high capacity for uptake of 
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lipid binding proteins and lipid regulating hormones (32). The decrease in kidney 
function observed in these mice could impair the kidneys ability to uptake lipids 
from the circulation, which would increase the total circulating blood lipids, thus 
increasing the chances of atherosclerotic lesions.  
 
4.3 Inflammation  
 LPS is an endotoxin released by gram-negative bacteria, which elicits an 
immune response in animals, including inflammation. During an immune 
response, macrophages will migrate to the specific area needed and help 
mediate multiple processes including inflammation through cytokine release. We 
examined how our treatments influenced serum LPS levels, influx of 
macrophages to the kidney, the levels of cytokines in the kidney, and the amount 
of cytokines produced by activated macrophages. 
 Blood samples were taken from each of the mice after the experiment was 
completed to test for serum LPS levels. Figure 7 demonstrates that all of the 
treatment groups had elevated serum LPS levels compared to the control.  The 
HFD group had serum LPS levels significantly higher than the control and the 
PF-HFD group. This was expected based on previous research showing both 
humans and mice have increased absorption of LPS from the gut into the 
circulatory system following a high fat/high energy diet (27). The only difference 
between the HFD and the PF-HFD group was the amount of the high fat diet they 
consumed, so these data emphasize the impact that a high fat diet can have on 
serum LPS levels. The NX group had serum LPS levels that were significantly 
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raised above the control group and the PF-HFD group, but they were not 
significantly different than the HFD group. Our data suggest that both renal 
insufficiency as well as a high fat diet can significantly increase LPS levels. When 
a high fat diet is combined with renal insufficiency the highest serum LPS levels 
were observed. They were significantly higher than all other treatment groups. 
Both renal damage as well as a high fat diet can increase the absorption of LPS 
from the gut into circulation, so it was expected that when these two treatments 
were combined it would produce the highest serum LPS levels.  
 In order to quantify the influx of macrophages into the kidney we evaluated 
the levels of macrophage markers CD-68 and SR-1 using RT-PCR. Figures 8 
and 9 show that both of the markers had almost identical results for each of the 
treatments. All of the treatments had increased macrophage markers compared 
to the control. By binding to the TLR4 receptor of macrophages, LPS can activate 
the migration of macrophages to various organs in the body (28). The HFD group 
and the PF-HFD group had significantly different serum LPS levels, but their 
macrophage markers were not significantly different. This could suggest that LPS 
does play a role in macrophage migration. But other pathways could have a more 
substantial impact on the migration. The macrophage marker results followed a 
very similar path as the serum urea and creatinine levels. For both experiments 
the two treatments that had the most impact on macrophage influx and kidney 
function were the NX-Chow and NX-HFD group. This suggests that overall 
kidney function plays a major role in recruitment of macrophages. Similar to 
wound healing, macrophage influx to the kidneys is vital to the sterilization and 
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debridement of the tissue, followed by repair and rebuilding of the tissue (33, 34). 
The high fat diet alone causes some damage to kidney tissues and function, but 
nephrectomy has a more critical affect on tissue damage and kidney function. 
High fat diet combined with renal insufficiency resulted in the biggest decrease in 
kidney function, as well as the largest influx of macrophages to the kidney. The 
high fat diet has the capability to further exacerbate kidney dysfunction during 
renal insufficiency, and this can increase tissue damage, which results in the 
influx of macrophages to the kidneys to help with repair.  
 Cytokine release by macrophages activates the inflammatory pathway 
during an immune response. We assessed how our treatment groups affected 
the levels of TNF-α and IL-6 in the kidney, and also in activated macrophages. 
The results for both the TNF-α and the IL-6 were almost identical in the kidney 
and macrophages. For the kidney and the macrophages all the treatment groups 
were significantly higher than the control, and the NX-HFD groups had the 
highest cytokine levels that were significantly higher than the rest. The NX-Chow 
groups had significantly raised cytokine levels compared to the HFD. A high fat 
diet can cause an increase in cytokines in the kidneys and macrophages, but 
renal insufficiency plays a more crucial role in cytokine release. When a high fat 
diet is added to renal insufficiency it is able to exacerbate and further increase 
cytokine release in macrophages, and increase cytokine levels in the kidney. 
These four experiments compliment each other on the affects that occur when a 
high fat diet is present during renal insufficiency. Serum LPS levels are 
increased, there is an influx of macrophages to the kidneys, and these 
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macrophages produce more cytokines resulting in an increase in kidney cytokine 
levels, which ultimately leads to a larger inflammatory response.  
 Both PA and LPS activate inflammatory pathways. Therein they play a key 
role in disorders such as insulin resistance, CKD and atherosclerosis. 
Consumption of high fat diet not only leads to the increased blood levels of fatty 
acids such as PA but also increases absorption of LPS from the gut (9, 31). 
Although the amount of LPS generated from high fat diet does not cause 
pronounced inflammation such as seen in septic shock, low levels or sub-clinical 
levels of LPS, which can be generated following chronic consumption of high fat 
diet, can sensitize cells to produce significant inflammation (35, 36). Mouse 
macrophages (J774) were transduced with adenoviral NFkB with a luciferase 
reporter and treated with different concentrations of PA and LPS. Assessing the 
activation of NFkB was performed to measure inflammatory response. We used 
three different concentrations of PA, and two different concentrations of LPS. The 
three concentrations of PA that we used are similar to those found in humans on 
a high fat diet. The low concentration of LPS we used is also similar to levels 
seen in humans on a high fat diet, and the high concentration of LPS was used to 
demonstrate the inflammatory activating capability of LPS through NFkB 
activation. Figure 20 shows that low levels of LPS do not elicit much of an 
inflammatory response alone, but can markedly exaggerate the inflammatory 
potential of various concentrations of PA.  The 150 µM of PA and the low dose of 
LPS by themselves were not able to significantly increase NFkB activation 
compared to the control. When the 150 µM of PA was first primed by 50 pg/mL of 
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LPS the NFkB activation increased significantly more than the control and the 
150 µM PA by itself. Similar results occurred when the 300 µM of PA was first 
primed with 50 pg/mL of LPS. The 300 µM PA by itself was able to activate NFkB 
significantly more than the control, but when primed with 50 pg/mL of LPS the 
NFkB activation increased significantly more than 300 µM PA by itself.  
 To confirm these results we looked at the phosphorylation of NFkB by 
immunoblot analysis. Increased phosphorylation, i.e. increased ratio of 
pNFkB/NFkB, reflects augmented inflammation. The results we obtained were 
very similar to the adenoviral study we performed with NFkB luciferase activation. 
The pNFkB/NFkB Ratio was not statistically different between the 150 µM PA by 
itself and the control. When the 150 µM PA was primed with 50 pg/mL of LPS the 
ratio significantly increased more than the control and the 150 µM PA alone. 
Similar results occurred when the 300 µM of PA was first primed with 50 pg/mL 
of LPS. The 300 µM PA by itself was able to increase the pNFkB/NFkB ratio 
significantly more than the control, but when primed with 50 pg/mL of LPS the 
pNFkB/NFkB was further increased to be significantly more than 300 µM PA by 
itself. This demonstrates that when PA is primed with low doses of LPS it results 
in an increased pNFkB/NFkB ratio, which ultimately leads to a greater 
inflammatory response.  
 These results suggest that PA from high fat diet can activate NFkB and 
inflammation, which can be significantly aggravated by LPS released in the 
circulation after high fat diet. These low levels of LPS are not enough to initiate 
an inflammatory response through NFkB activation, but it seems as though they 
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might sensitize the TLR4 to other effectors. LPS has shown to increase TLR4 
expression in adipocytes, and a similar mechanism could also be occurring in 
macrophages (37). 
 
4.4 Conclusion 
  The results from our studies showed a high fat diet combined with renal 
insufficiency significantly aggravated kidney disease and associated disorders 
compared to both a high fat diet and renal insufficiency alone. Additionally, we 
were able to demonstrate in vitro that the combination of LPS and palmitic acid, a 
marker of high fat diet, induced inflammatory pathways significantly more than 
either LPS or palmitic acid alone. These results support the hypothesis that LPS 
from a high fat diet is able to amplify inflammation, thereby exacerbating chronic 
kidney disease and its associated disorders. These results provide insight into 
connection between a high fat diet and the progression of chronic kidney disease 
as well as associated disorders.   
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